Bibliografische Daten

Dokument WO002011073092A1 (Seiten: 45)

Bibliografische Daten Dokument WO002011073092A1 (Seiten: 45)
INID Kriterium Feld Inhalt
54 Titel TI [EN] 3-(INDOLYL)- OR 3-(AZAINDOLYL)-4-ARYLMALEIMIDE COMPOUNDS AND THEIR USE IN TUMOR TREATMENT
[FR] COMPOSÉS DE 3-(INDOLYL) OU 3-(AZAINDOLYL)-4-ARYLMALÉIMIDE ET LEUR UTILISATION DANS LE TRAITEMENT DES TUMEURS
71/73 Anmelder/Inhaber PA DANNHARDT GERD, DE ; KRAMB JAN-PETER, DE ; PLUTIZKI STANISLAV, DE ; UNIV MAINZ JOHANNES GUTENBERG, DE
72 Erfinder IN DANNHARDT GERD, DE ; KRAMB JAN-PETER, DE ; PLUTIZKI STANISLAV, DE
22/96 Anmeldedatum AD 10.12.2010
21 Anmeldenummer AN 2010069352
Anmeldeland AC EP
Veröffentlichungsdatum PUB 23.06.2011
33
31
32
Priorität PRC
PRN
PRD
EP
09179986
20091218
51 IPC-Hauptklasse ICM C07D 403/04 (2006.01)
51 IPC-Nebenklasse ICS A61K 31/404 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
C07D 471/04 (2006.01)
IPC-Zusatzklasse ICA
IPC-Indexklasse ICI
Gemeinsame Patentklassifikation CPC A61K 31/404
A61K 31/437
A61K 31/454
A61K 31/4745
A61K 31/496
A61K 31/5377
A61K 45/06
A61P 35/00
C07D 403/04
C07D 471/04
MCD-Hauptklasse MCM C07D 403/04 (2006.01)
MCD-Nebenklasse MCS A61K 31/404 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
C07D 471/04 (2006.01)
MCD-Zusatzklasse MCA
57 Zusammenfassung AB [EN] The present invention relates to a compound of formula (I) wherein R1, R2 and R3 are as defined in the description and the physiologically acceptable salts thereof as well as the physiologically acceptable solvates of the compounds of formula I and of the salts thereof. The compounds of formula I are suitable for treating tumors.
[FR] L'invention concerne des composés de formule (I) dans laquelle R1, R2 et R3 sont tels que définis dans la description et leurs sels physiologiquement acceptables, ainsi que les solvates physiologiquement acceptables des composés de formule I et de leurs sels. Les composés de formule I sont adaptés au traitement des tumeurs.
56 Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt
CT WO002003095452A1
WO002006061212A1
WO002009010542A1
56 Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt
CT EP000000328026A1
EP000000384349A1
EP000000540956A1
EP000001224932A1
WO001991013071A1
WO001995007910A1
WO001997034890A1
WO002000021927A2
WO002000038675A1
WO002002010158A2
WO002002038561A1
WO002003057202A1
WO002003103663A2
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt
CTNP
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt
CTNP BASEL ET AL., J. ORG. CHEM., vol. 65, no. 20, 2000, pages 6368 - 6380 1;
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, 2004, pages 3245 - 3250 1;
CASH ET AL., ORG. BIOMOL. CHEM., vol. 3, 2005, pages 3701 - 3706 1;
CATARZI ET AL., ARCH. PHARM. (WEINHEIM), vol. 330, no. 12, 1997, pages 383 - 386 1;
FAUL ET AL., J. OF ORGANIC CHEMISTRY, vol. 63, no. 6, 1998, pages 1961 - 1973 1;
GALKA ET AL., J. LAB. COMP. RAD., vol. 48, no. 11, 2005, pages 797 - 809 1;
J HETEROCYCL. CHEM., vol. 29, 1992, pages 359 - 363 1;
J MED. CHEM., vol. 49, no. 4, 2006, pages 1271 - 1281 1;
J. MED. CHEM., vol. 49, 2006, pages 1271 - 1281 1;
J. MED. CHEM., vol. 49, 2006, pages 7549 - 7553 1;
J. ORG. CHEM., vol. 67, 2002, pages 2345 - 2347 1;
J. ORG. CHEM., vol. 67, 2002, pages 6226 - 6227 1;
MAHESH ET AL., PHARMAZIE, vol. 60, no. 6, 2005, pages 411 - 414 1;
MOSMANN, T. ET AL., J.IMMUNOL.METHODS, vol. 65, 1983, pages 55 - 63 1;
NICOLETTI, 1. ET AL., J. IMMUNOL. METHODS, vol. 139, 1991, pages 271 - 279 1;
ORG.BIOMOL. CHEM., vol. 3, no. 20, 2005, pages 3701 - 3706 1;
ORGANIC LETTERS, vol. 2, no. 10, 2000, pages 1485 - 1487 1;
PEIFER ET AL., J. MED. CHEM., vol. 49, 2006, pages 7549 - 7553 1;
POMMIER, Y., NATURE REVIEWS CANCER, vol. 6, 2006, pages 789 - 802 1;
SYNTHESIS, vol. 7, 1996, pages 877 - 882 1;
TETRAHEDRON LETTERS, vol. 40, 1999, pages 1109 - 1112 1;
TETRAHEDRON, vol. 55, no. 43, 1999, pages 12577 - 12594 1;
WESCOTT ET AL., J. ORG. CHEM., vol. 68, no. 26, 2003, pages 10058 - 10066 1;
ZHANG ET AL., BIOORG. MED. CHEM. LETT., vol. 14, no. 12, 2004, pages 3245 - 3250 1
Zitierende Dokumente Dokumente ermitteln
Sequenzprotokoll
Prüfstoff-IPC ICP A61K 31/404
A61K 31/437
A61P 35/00
C07D 403/04
C07D 471/04